These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33918708)
1. Analysis of DnaK Expression from a Strain of Curreli S; Tettelin H; Benedetti F; Krishnan S; Cocchi F; Reitz M; Gallo RC; Zella D Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918708 [TBL] [Abstract][Full Text] [Related]
2. Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties. Zella D; Curreli S; Benedetti F; Krishnan S; Cocchi F; Latinovic OS; Denaro F; Romerio F; Djavani M; Charurat ME; Bryant JL; Tettelin H; Gallo RC Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12005-E12014. PubMed ID: 30509983 [TBL] [Abstract][Full Text] [Related]
3. Role of Mycoplasma Chaperone DnaK in Cellular Transformation. Benedetti F; Cocchi F; Latinovic OS; Curreli S; Krishnan S; Munawwar A; Gallo RC; Zella D Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075244 [TBL] [Abstract][Full Text] [Related]
4. Mycoplasma DnaK expression increases cancer development in vivo upon DNA damage. Benedetti F; Silvestri G; Denaro F; Finesso G; Contreras-Galindo R; Munawwar A; Williams S; Davis H; Bryant J; Wang Y; Radaelli E; Rathinam CV; Gallo RC; Zella D Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2320859121. PubMed ID: 38412130 [TBL] [Abstract][Full Text] [Related]
5. Mycoplasma DnaK increases DNA copy number variants in vivo. Benedetti F; Silvestri G; Saadat S; Denaro F; Latinovic OS; Davis H; Williams S; Bryant J; Ippodrino R; Rathinam CV; Gallo RC; Zella D Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2219897120. PubMed ID: 37459550 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactome profiling of Curreli S; Benedetti F; Yuan W; Munawwar A; Cocchi F; Gallo RC; Sherman NE; Zella D Front Microbiol; 2022; 13():1022704. PubMed ID: 36386669 [TBL] [Abstract][Full Text] [Related]
7. Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor. Afriat R; Horowitz S; Priel E PLoS One; 2013; 8(8):e72377. PubMed ID: 24013388 [TBL] [Abstract][Full Text] [Related]
8. The ftsZ gene as a tool for detection of Mycoplasma fermentans. Ofir R; Horowitz S; Wu Q; Weinstein Y Mol Cell Probes; 1998 Apr; 12(2):85-92. PubMed ID: 9633043 [TBL] [Abstract][Full Text] [Related]
9. Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains. Sasaki T; Sasaki Y; Kita M; Suzuki K; Watanabe H; Honda M J Clin Microbiol; 1992 Sep; 30(9):2435-40. PubMed ID: 1401012 [TBL] [Abstract][Full Text] [Related]
10. cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product. Hall RE; Agarwal S; Kestler DP; Cobb JA; Goldstein KM; Chang NS Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):919-27. PubMed ID: 8921000 [TBL] [Abstract][Full Text] [Related]
11. Fatal systemic infections of nonhuman primates by Mycoplasma fermentans (incognitus strain). Lo SC; Wear DJ; Shih JW; Wang RY; Newton PB; Rodriguez JF Clin Infect Dis; 1993 Aug; 17 Suppl 1():S283-8. PubMed ID: 8399931 [TBL] [Abstract][Full Text] [Related]
12. Animal model of Mycoplasma fermentans respiratory infection. Yáñez A; Martínez-Ramos A; Calixto T; González-Matus FJ; Rivera-Tapia JA; Giono S; Gil C; Cedillo L BMC Res Notes; 2013 Jan; 6():9. PubMed ID: 23298636 [TBL] [Abstract][Full Text] [Related]
13. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type 1-infected patients. Dawson MS; Hayes MM; Wang RY; Armstrong D; Kundsin RB; Lo SC Arch Pathol Lab Med; 1993 May; 117(5):511-4. PubMed ID: 8489341 [TBL] [Abstract][Full Text] [Related]
14. Observations on the possible origin of Mycoplasma fermentans incognitus strain based on antibiotic sensitivity tests. Hannan PC J Antimicrob Chemother; 1997 Jan; 39(1):25-30. PubMed ID: 9044024 [TBL] [Abstract][Full Text] [Related]
15. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. Hawkins RE; Rickman LS; Vermund SH; Carl M J Infect Dis; 1992 Mar; 165(3):581-5. PubMed ID: 1538164 [TBL] [Abstract][Full Text] [Related]
17. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Lo SC; Shih JW; Newton PB; Wong DM; Hayes MM; Benish JR; Wear DJ; Wang RY Am J Trop Med Hyg; 1989 Nov; 41(5):586-600. PubMed ID: 2817215 [TBL] [Abstract][Full Text] [Related]
18. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with Chronic Fatigue Syndrome. Vojdani A; Choppa PC; Tagle C; Andrin R; Samimi B; Lapp CW FEMS Immunol Med Microbiol; 1998 Dec; 22(4):355-65. PubMed ID: 9879928 [TBL] [Abstract][Full Text] [Related]
19. Identification and functional mapping of the Mycoplasma fermentans P29 adhesin. Leigh SA; Wise KS Infect Immun; 2002 Sep; 70(9):4925-35. PubMed ID: 12183538 [TBL] [Abstract][Full Text] [Related]
20. Models of infection due to mycoplasmas, including Mycoplasma fermentans, in the genital tract and other sites in mice. Taylor-Robinson D; Furr PM Clin Infect Dis; 1993 Aug; 17 Suppl 1():S280-2. PubMed ID: 8399930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]